SIMON KENT
Breitbart
Pfizer is ready to seek U.S. authorization for a third dose of its coronavirus vaccine, outlining Thursday a top up shot within 12 months could dramatically boost immunity and counter any virus mutant.
Pfizer’s Dr. Mikael Dolsten told the Associated Press early data from the company’s booster study suggests people’s antibody levels rise five- to 10-fold after a third dose, compared to their second dose months earlier.
Click the link below to read the rest of this story.
Click here to get more news from the Bulldog
On the go, but don’t want to miss any Bulldog news? Go to the App Store and downloads apps for Bulldog Reports and The Bulldog Show to your Apple and Android mobile devices. It’s free!
